Jasper Therapeutics Inc. (NASDAQ: JSPR) Stock Information | RedChip

Jasper Therapeutics Inc. (NASDAQ: JSPR) Listen to this Section


$18.01
-0.0900 ( -0.50% ) 118.1K

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Market Data


Open


$18.01

Previous close


$18.10

Volume


118.1K

Market cap


$273.10M

Day range


$17.61 - $18.35

52 week range


$4.00 - $31.01

Insider Ownership Transactions

Total Amount Purchased: 326,600.00 | $ 5,882,066.00

Date Type Amount Purchased Purchaser
2024-06-10 Sale -7500.00 Shizuru Judith Anne
2024-03-12 Sale -900.00 Mahal Jeetinder Singh
2024-02-20 Sale -100000.00 MARTELL RON
2024-02-20 Sale -40000.00 Mahal Jeetinder Singh
2024-02-20 Sale -40000.00 CROSS HERB
2024-02-20 Sale -45000.00 Tucker Edwin Jonathan
2024-02-12 Buy 190000.00 Carlyle Group Inc.
2024-02-09 Buy 350000.00 Velan Capital Investment Management LP
2023-11-30 Buy 10000.00 WIGGANS THOMAS G
2023-11-22 Buy 10000.00 WIGGANS THOMAS G

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 2 Jun 10, 2024
4 Insider transactions 1 Jun 10, 2024
4 Insider transactions 2 Jun 10, 2024
4 Insider transactions 2 Jun 10, 2024
4 Insider transactions 2 Jun 10, 2024
10-q Quarterly Reports 74 May 14, 2024
def Proxies and info statements 3 Apr 22, 2024
ars Annual reports 1 Apr 22, 2024
4 Insider transactions 1 Mar 12, 2024
10-k Annual reports 100 Mar 05, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.